🇺🇸 FDA
Pipeline program

ILUVIEN

M-01-13-002

Approved small_molecule completed

Quick answer

ILUVIEN for Chronic Diabetic Macular Edema is a Approved program (small_molecule) at ANI PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ANI PHARMACEUTICALS INC
Indication
Chronic Diabetic Macular Edema
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials